|
General Information
|
|
|
Product
|
SLC29A3 Peptide
|
|
Description
|
Antigenic Blocking Peptide Equilibrative Nucleoside Transporter 3 isoform A Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
NCBI: NP_060814.4
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9BZD2
|
|
Overview
|
Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter)
|
|
Molecular Function
|
nucleoside transmembrane transporter activity
|
|
Subcellular Location
|
Endosome, Lysosome, Membrane
|
|
Expression
|
Widely expressed in both adult and fetal tissues. Highest levels in placenta, uterus, ovary, spleen, lymph node and bone marrow. Lowest levels in brain and heart
|
|
Structure
|
Belongs to the SLC29A/ENT transporter (TC 2.A.57) family
|
|
Alternative Nomenclature
|
ENT3 antibody
Equilibrative nucleoside transporter 3 antibody
HCLAP antibody
hENT3 antibody
HJCD antibody
PHID antibody
SLC29A3 antibody
solute carrier family 29 (equilibrative nucleoside transporter), member 3 antibody
|
| |
|
SLC29A3 Antibody
SLC29A3 Antibody FITC
SLC29A3 Antibody BIOTIN
SLC29A3 Positive Control
